FDA issues draft guidance on tissue-based products

FDA is seeking comments on draft guidance on reporting adverse reactions related to human cells, tissues and cellular and tissue-based products that are intended for implantation, transplantation, infusion or transfer into a human recipient. The guidance, designed to prevent transmission of communicable diseases, mandates that a manufacturer submit a report to FDA within 15 days of receiving information about an adverse reaction. ...